Profitable biotech heavyweights such as Amgen and Genentech are being joined by a new generation of companies that have successfully shepherded drugs through to regulatory approval, said Gautam Jaggi, managing editor of Beyond Borders: Global Biotechnology Report 2007. Profitable biotech heavyweights such as Amgen and Genentech are being joined by a new generation of companies that have successfully shepherded drugs through to regulatory approval, said Gautam Jaggi, managing editor of...

Researchers say genetic engineering could help fight the spread of a disease that is killing crops in parts of the south pacific. That's why about a hundred people protested at the state capitol this morning, against the genetic modification of taro. A senate bill, banning the genetic engineering of taro, could soon die in the 2007 legislative session. Native Hawaiians feel genetically engineered taro will contaminate the purity of the crop. Those who support genetic manipulation of taro...

There is ample evidence from both the Bible and extra-biblical books that shows strong disapproval of genetic engineering. Yet, it may quite possibly be the most important question of all regarding all aspects of biotechnology. Bible disapproves genetic engineering. Tuesday, March 27, 2007 - FreeMarketNews.com Quite surprisingly, this question is one that has rarely been discussed by anyone in the scientific community. Free-Market News Network does not represent, warrant, or endorse the...

Companies that seek to market comparable generic versions of biotech medications would have to prove that their treatments have active ingredients "similar" to those of the brand-name versions. Companies that seek to market interchangeable generic biotech medications would have to prove that their treatments have molecular structures "comparable" to those of the brand-name versions and that their treatments have the same effects as the brand-name versions in all patients. Companies that...

biotech CEOs say they plan to do a deal within the next couple of years. And the report points out that the bullish trends show no signs of letting up because "big pharma's voracious need to fill the pipeline in the shadow of blockbuster patent expirations -- has clearly shifted the balance of power at the negotiating table toward biotechnology companies. biotech CEOs say they plan to do a deal within the next couple of years. And the report points out that the bullish trends show no signs...

Home Database News Resources Nanowerk Nanotechnology Introduction Career Center Nanotechnology News . Nanowerk Spotlight Periodicals . Books . Links Database . Reports . Encyclop dia . Events . Debate . Neat Stuff About Us . Link to Us . Contact Us . Nanotechnology News RSS Feed E-mail this article. Home Database News Resources Nanowerk Nanotechnology Introduction Career Center Nanotechnology News . Nanowerk Spotlight Periodicals . Books . Links Database . Reports . Encyclop dia . Events ....

Web Posted: 03/31/2007 01:44 AM CDT Don Finley Express-News Medical Writer A small mound of fruit flies sleeps en masse on a rubber pad beneath Gregory Macleod's microscope, the pad releasing a faint hiss of carbon dioxide to maintain their peaceful fly slumbers. Web Posted: 03/31/2007 01:44 AM CDT Don Finley Express-News Medical Writer A small mound of fruit flies sleeps en masse on a rubber pad beneath Gregory Macleod's microscope, the pad releasing a faint hiss of carbon dioxide to...

Peter Robson 30 March 2007 Greenpeace has revealed that an independent report into safety testing by genetic engineering giant Monsanto was ignored in the lead-up to a vote on whether the company s new genetically engineered maize would be approved for consumption in the European Union. About Donate Subscribe Activist Calendar Links Contact Us Google search . Advanced search. Peter Robson 30 March 2007 Greenpeace has revealed that an independent report into safety testing by genetic...

lawson@htimes.com The promises of biotechnology are vast and Huntsville is expected to play an increasing role in shaping biotechnology's future research. With plenty of work to be done, some 80 students from Huntsville area colleges, as well as Vanderbilt, Auburn and the University of Alabama at Birmingham, came to Huntsville last week to learn more, gain career-hunting skills and network with biotech company officials at a workshop and meeting at the Von Braun Center. With plenty of work...